| Jenice Michelle Martinez, RN | |
|
2895 Lewis Ln, Paris, TX 75460-9331 | |
| (972) 203-3600 | |
| Not Available |
| Full Name | Jenice Michelle Martinez |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 3 Years |
| Location | 2895 Lewis Ln, Paris, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1790273464 | NPI | - | NPPES |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Paragon Pain And Rehabilitation Llp | 2466616032 | 15 |
News Archive
A novel therapy that reduces elevated blood levels of a potentially toxic protein in women with preeclampsia, a dangerous complication of pregnancy, may someday address the therapeutic dilemma posed by the condition - balancing life-threatening risks to the mother with the dangers that early delivery poses to an immature fetus.
Phase III clinical study comparing placebo to rimonabant, the first agent in a new therapeutic class known as selective cannabinoid type 1 (CB1) blockers, showed that overweight or obese people taking rimonabant 20mg once daily benefited from a significant reduction in their body weight
The Associated Press: "States cut funding for state tobacco prevention programs more than 15 percent this year, pushing it further than ever below federally recommended levels, according to a report that a coalition of public health groups is releasing Wednesday.
MDS Inc., a leading provider of products and services to the global life sciences markets, today announced that it has signed an agreement to sell its Central Labs operation, which conducts analysis of samples from late-stage clinical trials to Czura Thornton, a private investment group based in Jersey, Channel Islands.
Scientists at the University of Sheffield have discovered new ways to help detect and treat the debilitating brittle bone disease osteoporosis.
› Verified 6 days ago
| Entity Name | Paragon Pain & Rehabilitation Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780958777 PECOS PAC ID: 2466616032 Enrollment ID: O20120611000491 |
News Archive
A novel therapy that reduces elevated blood levels of a potentially toxic protein in women with preeclampsia, a dangerous complication of pregnancy, may someday address the therapeutic dilemma posed by the condition - balancing life-threatening risks to the mother with the dangers that early delivery poses to an immature fetus.
Phase III clinical study comparing placebo to rimonabant, the first agent in a new therapeutic class known as selective cannabinoid type 1 (CB1) blockers, showed that overweight or obese people taking rimonabant 20mg once daily benefited from a significant reduction in their body weight
The Associated Press: "States cut funding for state tobacco prevention programs more than 15 percent this year, pushing it further than ever below federally recommended levels, according to a report that a coalition of public health groups is releasing Wednesday.
MDS Inc., a leading provider of products and services to the global life sciences markets, today announced that it has signed an agreement to sell its Central Labs operation, which conducts analysis of samples from late-stage clinical trials to Czura Thornton, a private investment group based in Jersey, Channel Islands.
Scientists at the University of Sheffield have discovered new ways to help detect and treat the debilitating brittle bone disease osteoporosis.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jenice Michelle Martinez, RN Po Box 1405, Quinlan, TX 75474-0024 Ph: (214) 868-5361 | Jenice Michelle Martinez, RN 2895 Lewis Ln, Paris, TX 75460-9331 Ph: (972) 203-3600 |
News Archive
A novel therapy that reduces elevated blood levels of a potentially toxic protein in women with preeclampsia, a dangerous complication of pregnancy, may someday address the therapeutic dilemma posed by the condition - balancing life-threatening risks to the mother with the dangers that early delivery poses to an immature fetus.
Phase III clinical study comparing placebo to rimonabant, the first agent in a new therapeutic class known as selective cannabinoid type 1 (CB1) blockers, showed that overweight or obese people taking rimonabant 20mg once daily benefited from a significant reduction in their body weight
The Associated Press: "States cut funding for state tobacco prevention programs more than 15 percent this year, pushing it further than ever below federally recommended levels, according to a report that a coalition of public health groups is releasing Wednesday.
MDS Inc., a leading provider of products and services to the global life sciences markets, today announced that it has signed an agreement to sell its Central Labs operation, which conducts analysis of samples from late-stage clinical trials to Czura Thornton, a private investment group based in Jersey, Channel Islands.
Scientists at the University of Sheffield have discovered new ways to help detect and treat the debilitating brittle bone disease osteoporosis.
› Verified 6 days ago